329 related articles for article (PubMed ID: 34837569)
1. Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network.
Raiker R; Pakhchanian H; Kavadichanda C; Gupta L; Kardeş S; Ahmed S
Clin Rheumatol; 2022 Mar; 41(3):721-730. PubMed ID: 34837569
[TBL] [Abstract][Full Text] [Related]
2. Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort.
Torgutalp M; Rios Rodriguez V; Proft F; Protopopov M; Verba M; Rademacher J; Haibel H; Sieper J; Rudwaleit M; Poddubnyy D
Arthritis Rheumatol; 2022 Sep; 74(9):1515-1523. PubMed ID: 35437900
[TBL] [Abstract][Full Text] [Related]
3. A nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan.
Matsubara Y; Nakamura Y; Tamura N; Kameda H; Otomo K; Kishimoto M; Kadono Y; Tsuji S; Atsumi T; Matsuno H; Takagi M; Kobayashi S; Fujio K; Nishimoto N; Okamoto N; Nakajima A; Matsui K; Yamamura M; Nakashima Y; Kawakami A; Mori M; Tomita T
Mod Rheumatol; 2022 Aug; 32(5):960-967. PubMed ID: 34755187
[TBL] [Abstract][Full Text] [Related]
4. Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.
Raiker R; Pakhchanian H; DeYoung C; Gupta L; Kardeş S; Ahmed S; Kavadichanda C
J Autoimmun; 2021 Dec; 125():102730. PubMed ID: 34649723
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States.
Raiker R; DeYoung C; Pakhchanian H; Ahmed S; Kavadichanda C; Gupta L; Kardeş S
Semin Arthritis Rheum; 2021 Oct; 51(5):1057-1066. PubMed ID: 34450504
[TBL] [Abstract][Full Text] [Related]
7. Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis.
G S Saad C; S R Silva M; Sampaio-Barros PD; C B Moraes J; G Schainberg C; Gonçalves CR; Shimabuco AY; Aikawa NE; F N Yuki E; G Pasoto S; V K Kupa L; K Aoyama R; S R Araujo C; Silva CA; Medeiros-Ribeiro AC; Bonfa E
Joint Bone Spine; 2023 Jan; 90(1):105464. PubMed ID: 36150668
[TBL] [Abstract][Full Text] [Related]
8. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
9. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.
Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LT; Kristensen LE; Feltelius N; Hetland ML; Askling J;
Ann Rheum Dis; 2017 Jan; 76(1):105-111. PubMed ID: 27147709
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.
Monti S; Todoerti M; Codullo V; Favalli EG; Biggioggero M; Becciolini A; Montecucco C; Caporali R
Mod Rheumatol; 2018 May; 28(3):542-549. PubMed ID: 28880727
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonographic Evaluation of Nail Involvement in Patients With Axial Spondyloarthritis.
Kulaksız B; Palamar D; Misirlioglu TO; Akgun K; Terlemez R
J Ultrasound Med; 2024 May; 43(5):967-978. PubMed ID: 38323351
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Non-radiographic Axial Spondyloarthritis and Ankylosing Spondyltis from a Single Rheumatology Hospital in Morocco.
Akasbi N; Nihad S; Sofia Z; Khadija EK; Taoufik H
Curr Rheumatol Rev; 2020; 16(3):240-244. PubMed ID: 30806321
[TBL] [Abstract][Full Text] [Related]
15. Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials.
Toussirot E; Vauchy C; Binda D; Michel F
Drug Des Devel Ther; 2016; 10():2087-94. PubMed ID: 27445459
[TBL] [Abstract][Full Text] [Related]
16. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
[TBL] [Abstract][Full Text] [Related]
17. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
18. Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort.
Ciurea A; Kissling S; Bürki K; Baraliakos X; de Hooge M; Hebeisen M; Papagiannoulis E; Exer P; Bräm R; Nissen MJ; Möller B; Kyburz D; Andor M; Distler O; Scherer A; Micheroli R
RMD Open; 2022 Feb; 8(1):. PubMed ID: 35110365
[TBL] [Abstract][Full Text] [Related]
19. Non-radiographic axial spondyloarthritis in Tunisia: main characteristics and detailed comparison with ankylosing spondylitis.
Ben Abdelghani K; Gzam Y; Fazaa A; Miladi S; Sellami M; Souabni L; Kassab S; Chekili S; Zakraoui L; Laater A
Clin Rheumatol; 2021 Apr; 40(4):1361-1367. PubMed ID: 32974836
[TBL] [Abstract][Full Text] [Related]
20. Role of Metrology in Axial Spondyloarthritis: Does It Provide Unique Information in Assessing Patients and Predicting Outcome? Results From the British Society for Rheumatology Biologic Register for Ankylosing Spondylitis.
Biallas RL; Dean LE; Davidson L; Hollick R; Pathan E; Robertson L; Jones GT; Macfarlane GJ; Rotariu O
Arthritis Care Res (Hoboken); 2022 Apr; 74(4):665-674. PubMed ID: 33140891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
